| Q57309657 | A Multicenter Study of BRD2 as a Risk Factor for Juvenile Myoclonic Epilepsy |
| Q43688794 | A clinical and electroencephalographic study of juvenile myoclonic epilepsy: its pathophysiological considerations based on the findings obtained from neuropsychological EEG activation |
| Q67512379 | A controlled social and psychological investigation of patients with juvenile myoclonic epilepsy |
| Q48199147 | A locus for juvenile myoclonic epilepsy maps to 2q33-q36. |
| Q30662597 | A meta-analysis of voxel-based morphometry studies on gray matter volume alteration in juvenile myoclonic epilepsy |
| Q87909027 | A novel SCN1A mutation in a cytoplasmic loop in intractable juvenile myoclonic epilepsy without febrile seizures |
| Q34099192 | A novel gene in the chromosomal region for juvenile myoclonic epilepsy on 6p12 encodes a brain-specific lysosomal membrane protein |
| Q80152328 | A novel genetic locus for juvenile myoclonic epilepsy at chromosome 5q12-q14 |
| Q73089727 | A special kind of anterior horn cell involvement in juvenile myoclonic epilepsy demonstrated by macro electromyography |
| Q71031697 | A study of the association between Japanese juvenile myoclonic epilepsy patients and HLA class II antigens |
| Q59600658 | Abnormal cerebral structure in juvenile myoclonic epilepsy demonstrated with voxel-based analysis of MRI |
| Q92308762 | Abnormal hippocampal structure and function in juvenile myoclonic epilepsy and unaffected siblings |
| Q85660169 | Abnormal motor cortex plasticity in juvenile myoclonic epilepsy |
| Q87952352 | Abnormal response to photic stimulation in juvenile myoclonic epilepsy: an EEG-fMRI study |
| Q47568787 | Absence Seizures as a Feature of Juvenile Myoclonic Epilepsy in Rhodesian Ridgeback Dogs. |
| Q79314227 | Absence of GABRA1 Ala322Asp mutation in juvenile myoclonic epilepsy families from India |
| Q41835514 | Absences in juvenile myoclonic epilepsy: a clinical and video-electroencephalographic study |
| Q92610410 | Alteration of cerebello-thalamocortical spontaneous low-frequency oscillations in juvenile myoclonic epilepsy |
| Q60681504 | Alterations in pain responsiveness and serum biomarkers in juvenile myoclonic epilepsy: an age- and gender-matched controlled pilot study |
| Q36448488 | Altered Local Spontaneous Brain Activity in Juvenile Myoclonic Epilepsy: A Preliminary Resting-State fMRI Study |
| Q55284234 | Altered Structural and Functional Connectivity of Juvenile Myoclonic Epilepsy: An fMRI Study. |
| Q99575962 | Altered dynamic effective connectivity of the default mode network in newly diagnosed drug-naïve juvenile myoclonic epilepsy |
| Q35948522 | Altered microstructural connectivity in juvenile myoclonic epilepsy: the missing link |
| Q71290244 | Analysis of a human brain voltage-gated potassium channel gene, KCNA6 (HBK2), in patients with juvenile myoclonic epilepsy |
| Q80726619 | Analysis of background EEG activity in patients with juvenile myoclonic epilepsy |
| Q71889337 | Anterior horn cells might be subclinically affected in juvenile myoclonic epilepsy (JME) |
| Q58085839 | Antiepileptic drug withdrawal in juvenile myoclonic epilepsy |
| Q46033338 | Are personality traits of juvenile myoclonic epilepsy related to frontal lobe dysfunctions? A proton MRS study. |
| Q71512908 | Association of HLA class II alleles in patients with juvenile myoclonic epilepsy compared with patients with other forms of adolescent-onset generalized epilepsy |
| Q46728551 | Association of serotonin transporter gene (5HTT) polymorphism and juvenile myoclonic epilepsy: a case-control study |
| Q87905119 | Association of the GRM4 gene variants with juvenile myoclonic epilepsy in an Indian population |
| Q24675229 | Association of the connexin36 gene with juvenile myoclonic epilepsy |
| Q86986705 | Auditory startle response is normal in juvenile myoclonic epilepsy |
| Q100447583 | Automated Detection of Juvenile Myoclonic Epilepsy using CNN based Transfer Learning in Diffusion MRI |
| Q35929810 | Autosomal dominant juvenile myoclonic epilepsy and GABRA1. |
| Q83008202 | Axonemal protofilament ribbons, DM10 domains, and the link to juvenile myoclonic epilepsy |
| Q64104606 | BOLD-fMRI activity informed by network variation of scalp EEG in juvenile myoclonic epilepsy |
| Q24532132 | BRD2 (RING3) is a probable major susceptibility gene for common juvenile myoclonic epilepsy |
| Q41315653 | Behavioral and Movement Disorders due to Long-Lasting Myoclonic Status Epilepticus Misdiagnosed as ADHD in a Patient With Juvenile Myoclonic Epilepsy: Electroclinical Findings and Related Hemodynamic Changes |
| Q70362129 | Benign juvenile myoclonic epilepsy |
| Q63402070 | Biology of Juvenile Myoclonic Epilepsy |
| Q48189934 | Brain morphology in juvenile myoclonic epilepsy and absence seizures |
| Q48247353 | CBF changes in drug naive juvenile myoclonic epilepsy patients |
| Q79216055 | Candidate gene analysis of the human metabotropic glutamate receptor type 4 (GRM4) in patients with juvenile myoclonic epilepsy |
| Q33732406 | Carbamazepine in the treatment of generalised tonic clonic seizures in juvenile myoclonic epilepsy |
| Q104507705 | Case Report: Four Cases of Panayiotopoulos Syndrome Evolving to Juvenile Myoclonic Epilepsy |
| Q46141701 | Case of juvenile myoclonic epilepsy misdiagnosed as simple partial seizure for more than 60 years |
| Q55396526 | Changes in Dynamics Within and Between Resting-State Subnetworks in Juvenile Myoclonic Epilepsy Occur at Multiple Frequency Bands. |
| Q83888938 | Channelopathies and juvenile myoclonic epilepsy |
| Q40742729 | Characterization of intractable juvenile myoclonic epilepsy: new perspectives on primarily generalized seizures |
| Q38289666 | Characterization of the C-terminal half of human juvenile myoclonic epilepsy protein EFHC1: dimer formation blocks Ca2+ and Mg2+ binding to its functional EF-hand |
| Q80917186 | Childhood absence epilepsy evolving to juvenile myoclonic epilepsy: electroclinical and genetic features |
| Q36706639 | Chromosome loci vary by juvenile myoclonic epilepsy subsyndromes: linkage and haplotype analysis applied to epilepsy and EEG 3.5-6.0 Hz polyspike waves. |
| Q28329662 | Chronic acetazolamide monotherapy in the treatment of juvenile myoclonic epilepsy |
| Q41548911 | Circadian rhythm and profile in patients with juvenile myoclonic epilepsy and temporal lobe epilepsy. |
| Q33935063 | Classification of juvenile myoclonic epilepsy data acquired through scanning electromyography with machine learning algorithms. |
| Q30388636 | Clinical Evaluation of 38 Patients with Juvenile Myoclonic Epilepsy |
| Q72361128 | Clinical and EEG asymmetries in juvenile myoclonic epilepsy |
| Q73106994 | Clinical and EEG asymmetries in juvenile myoclonic epilepsy (JME) |
| Q82634205 | Clinical and electroencephalographic study of first-degree relatives and probands with juvenile myoclonic epilepsy |
| Q47633592 | Clinical characteristics of a South Indian cohort of juvenile myoclonic epilepsy probands |
| Q44140763 | Clinical expression and EEG features of patients with juvenile myoclonic epilepsy (JME) from North India |
| Q92551433 | Clinical features and treatment outcomes of Juvenile myoclonic epilepsy patients |
| Q73568759 | Clinical features, EEG findings and diagnostic pitfalls in juvenile myoclonic epilepsy: a series of 63 patients |
| Q87535863 | Clinical genetic study in juvenile myoclonic epilepsy |
| Q87262983 | Clinical heterogeneity of juvenile myoclonic epilepsy: follow-up after an interval of more than 20 years |
| Q48488077 | Clinical observations of juvenile myoclonic epilepsy in 131 patients: a study in South India |
| Q38177883 | Clinical predictors of the long-term social outcome and quality of life in juvenile myoclonic epilepsy: 20-65 years of follow-up |
| Q90369472 | Cognitive functioning in new-onset juvenile myoclonic epilepsy |
| Q37203286 | Cognitive impairment in juvenile myoclonic epilepsy |
| Q47842991 | Cognitive performance in juvenile myoclonic epilepsy patients with specific endophenotypes |
| Q92840537 | Colour vision in juvenile myoclonic epilepsy |
| Q80345912 | Comment to: overlap cases of eyelid myoclonia with absences and juvenile myoclonic epilepsy |
| Q92803700 | Comparative effectiveness of antiepileptic drugs in juvenile myoclonic epilepsy |
| Q47780728 | Comparing sleep profiles between patients with juvenile myoclonic epilepsy and symptomatic partial epilepsy: Sleep questionnaire-based study |
| Q79801668 | Comparison of valporic acid efficacy in familial versus sporadic cases of juvenile myoclonic epilepsy |
| Q39782946 | Complex discharge-affecting networks in juvenile myoclonic epilepsy: A simultaneous EEG-fMRI study |
| Q35121903 | Complex inheritance and parent-of-origin effect in juvenile myoclonic epilepsy |
| Q38220460 | Concepts and controversies of juvenile myoclonic epilepsy: still an enigmatic epilepsy |
| Q43866407 | Confirmation of linkage between juvenile myoclonic epilepsy locus and the HLA region of chromosome 6. |
| Q59600505 | Connectivity of the supplementary motor area in juvenile myoclonic epilepsy and frontal lobe epilepsy |
| Q80567661 | Cortical thickness abnormality in juvenile myoclonic epilepsy |
| Q56781160 | Corticospinal excitability in juvenile myoclonic epilepsy: The story so far |
| Q88244914 | DNA methylation of the BRD2 promoter is associated with juvenile myoclonic epilepsy in Caucasians |
| Q24514943 | Delayed diagnosis of juvenile myoclonic epilepsy |
| Q58833699 | Delineating a new critical region for juvenile myoclonic epilepsy at the 22q11.2 chromosome |
| Q41034643 | Delineating behavioral and cognitive phenotypes in juvenile myoclonic epilepsy: Are we missing the forest for the trees? |
| Q92009910 | Developmental decrease in parvalbumin-positive neurons precedes increase in flurothyl-induced seizure susceptibility in the Brd2+/- mouse model of juvenile myoclonic epilepsy |
| Q67885405 | Diagnosing juvenile myoclonic epilepsy |
| Q71987056 | Diagnosing juvenile myoclonic epilepsy in an elderly patient |
| Q36383785 | Differential improvement of the sleep quality among patients with juvenile myoclonic epilepsy with valproic acid: A longitudinal sleep questionnaire-based study |
| Q39163904 | Dimorphism of TAP-1 gene in Caucasian with juvenile myoclonic epilepsy and in Tunisian with idiopathic generalized epilepsies |
| Q91072278 | Dissociation between decision making under ambiguity and risk in patients with juvenile myoclonic epilepsy |
| Q60440850 | Distinct domains of impulsivity are impaired in juvenile myoclonic epilepsy but not in temporal lobe epilepsy |
| Q90265051 | Drug-Resistant Juvenile Myoclonic Epilepsy: Misdiagnosis of Progressive Myoclonus Epilepsy |
| Q89877877 | Dysfunctional personality beliefs and executive performance in patients with juvenile myoclonic epilepsy |
| Q54129995 | EFHC1 mutation in Indian juvenile myoclonic epilepsy patient. |
| Q46320813 | EFHC1 variants in juvenile myoclonic epilepsy: reanalysis according to NHGRI and ACMG guidelines for assigning disease causality |
| Q34545261 | EFHC1, a protein mutated in juvenile myoclonic epilepsy, associates with the mitotic spindle through its N-terminus. |
| Q64094566 | EFHC1, implicated in juvenile myoclonic epilepsy, functions at the cilium and synapse to modulate dopamine signaling |
| Q74351530 | Early and late intracortical inhibition in juvenile myoclonic epilepsy |
| Q47890820 | Effect of valproate on the sleep microstructure of juvenile myoclonic epilepsy patients - a cross-sectional CAP based study |
| Q37660972 | Effects of lamotrigine monotherapy in patients with newly diagnosed juvenile myoclonic epilepsy: An open-label study |
| Q36226208 | Effects of sleep deprivation on cortical excitability in patients affected by juvenile myoclonic epilepsy: a combined transcranial magnetic stimulation and EEG study. |
| Q87202393 | Efficacy and tolerability of lamotrigine in juvenile myoclonic epilepsy in adults: a prospective, unblinded randomized controlled trial |
| Q48586585 | Electroclinical aspects and therapy of Han patients with juvenile myoclonic epilepsy in northern China |
| Q77684054 | Electroencephalogram and clinical focalities in juvenile myoclonic epilepsy |
| Q38283089 | Epidemiology and clinical manifestations of juvenile myoclonic epilepsy (JME) in Iran |
| Q56519770 | Epilepsy with impulsive petit mal (Juvenile Myoclonic Epilepsy) |
| Q99608985 | Evaluating Executive Functions in Patients with Juvenile Myoclonic Epilepsy Using Frontal Assessment Battery |
| Q37735574 | Evaluation of Glutamic Acid Decarboxylase Antibody Levels in Patients with Juvenile Myoclonic Epilepsy and Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis |
| Q57990902 | Evaluation of a putative major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q14 |
| Q33858889 | Evaluation of a putative major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q14. |
| Q91591016 | Evaluation of genomic methylation indices in juvenile myoclonic epilepsy |
| Q44017821 | Evaluation of the positional candidate gene CHRNA7 at the juvenile myoclonic epilepsy locus (EJM2) on chromosome 15q13-14. |
| Q48486254 | Evidence that juvenile myoclonic epilepsy is a disorder of frontotemporal corticothalamic networks |
| Q48848720 | Evolution of childhood absence epilepsy, juvenile myoclonic epilepsy and epilepsy with grand mal on awakening |
| Q43793924 | Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate |
| Q80458648 | Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy |
| Q73289038 | Exacerbation of juvenile myoclonic epilepsy with lamotrigine |
| Q43619542 | Exacerbation of juvenile myoclonic epilepsy with lamotrigine |
| Q34479681 | Exclusion of the juvenile myoclonic epilepsy gene EFHC1 as the cause of migraine on chromosome 6, but association to two rare polymorphisms in MEP1A and RHAG. |
| Q87645608 | Expression of praxis induction on cortical excitability in juvenile myoclonic epilepsy |
| Q30983111 | Extrafrontal structural changes in juvenile myoclonic epilepsy: a topographic analysis of combined structural and microstructural brain imaging |
| Q49136346 | Eye closure sensitivity in juvenile myoclonic epilepsy and its effect on prognosis |
| Q48899676 | Eye closure sensitivity without photosensitivity in juvenile myoclonic epilepsy: polysomnographic study of electroencephalographic epileptiform discharge rates |
| Q73066830 | Factors of error involved in the diagnosis of juvenile myoclonic epilepsy: A study from South India |
| Q80917195 | Familial juvenile myoclonic epilepsy |
| Q48578885 | Focal epilepsy recruiting a generalised network of juvenile myoclonic epilepsy: a case report |
| Q30498019 | Focal structural changes and cognitive dysfunction in juvenile myoclonic epilepsy |
| Q48464526 | Frequency, causes and phenomenology of late seizure recurrence in patients with juvenile myoclonic epilepsy after a long period of remission |
| Q59222815 | Frontal cognitive dysfunction in juvenile myoclonic epilepsy |
| Q57123791 | Frontal lobe cognitive functions and electroencephalographic features in juvenile myoclonic epilepsy |
| Q27000713 | Frontal lobe function and structure in juvenile myoclonic epilepsy: a comprehensive review of neuropsychological and imaging data |
| Q48289392 | Fronto-insula network activity explains emotional dysfunctions in juvenile myoclonic epilepsy: combined evidence from pupillometry and fMRI. |
| Q90361779 | Functional Alterations in Ciliogenesis-Associated Kinase 1 (CILK1) that Result from Mutations Linked to Juvenile Myoclonic Epilepsy |
| Q34074424 | GABA(A) receptor alpha1 subunit mutation A322D associated with autosomal dominant juvenile myoclonic epilepsy reduces the expression and alters the composition of wild type GABA(A) receptors |
| Q37826794 | Gene mapping in the idiopathic generalized epilepsies: juvenile myoclonic epilepsy, childhood absence epilepsy, epilepsy with grand mal seizures, and early childhood myoclonic epilepsy |
| Q39126572 | Generalized epilepsy syndromes and callosal thickness: Differential effects between patients with juvenile myoclonic epilepsy and those with generalized tonic-clonic seizures alone |
| Q48221871 | Genetic association analysis of KCNQ3 and juvenile myoclonic epilepsy in a South Indian population |
| Q39163899 | Genetic linkage study of an autosomal recessive form of juvenile myoclonic epilepsy in a consanguineous Tunisian family |
| Q48650497 | Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q. |
| Q33821815 | Genetic susceptibility in Juvenile Myoclonic Epilepsy: Systematic review of genetic association studies. |
| Q35929803 | Genetics of juvenile myoclonic epilepsy: faulty components and faulty wiring? |
| Q49460204 | Grey and White Matter Alterations in Juvenile Myoclonic Epilepsy: A Comprehensive Review |
| Q42355550 | High-dose versus low-dose valproate for the treatment of juvenile myoclonic epilepsy: Going from low to high |
| Q90290473 | Higher IQ in juvenile myoclonic epilepsy: Dodging cognitive obstacles and "masking" impairments |
| Q83655022 | Hippocampal metabolic dysfunction in juvenile myoclonic epilepsy: 3D multivoxel spectroscopy study |
| Q34169927 | Hirayama disease with juvenile myoclonic epilepsy: A case report |
| Q33939977 | Homocarnosine and seizure control in juvenile myoclonic epilepsy and complex partial seizures |
| Q34988460 | Hyperconnectivity in juvenile myoclonic epilepsy: a network analysis |
| Q34146445 | Identification and mutational analysis of candidate genes for juvenile myoclonic epilepsy on 6p11-p12: LRRC1, GCLC, KIAA0057 and CLIC5. |
| Q100696714 | Impulsiveness, personality traits and executive functioning in patients with juvenile myoclonic epilepsy |
| Q48215736 | Interrelationship of sleep and juvenile myoclonic epilepsy (JME): a sleep questionnaire-, EEG-, and polysomnography (PSG)-based prospective case-control study |
| Q68446042 | Intestinal-Cell Kinase and Juvenile Myoclonic Epilepsy |
| Q72361134 | Is HLA-DRW13 (W6) associated with juvenile myoclonic epilepsy in Arab patients? |
| Q68344815 | Is juvenile myoclonic epilepsy an autosomal recessive disease? |
| Q41935602 | Juvenile Myoclonic Epilepsy (JME): Neuropsychological Profile and Related Factors with Cognitive Dysfunction |
| Q54967813 | Juvenile Myoclonic Epilepsy Presenting with Neurocognitive Impairment: A Case Report. |
| Q90219878 | Juvenile Myoclonic Epilepsy Shows Potential Structural White Matter Abnormalities: A TBSS Study |
| Q41587192 | Juvenile Myoclonic Epilepsy in Rural Western India: Not Yet a Benign Syndrome |
| Q41626203 | Juvenile Myoclonic Epilepsy with Frontal Executive Dysfunction is Associated with Reduced Gray Matter Volume by Voxel-based Morphometry. |
| Q67236402 | Juvenile myoclonic epilepsy (JME) may be linked to the BF and HLA loci on human chromosome 6 |
| Q49979238 | Juvenile myoclonic epilepsy - An insider's guide |
| Q49016879 | Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study |
| Q89324767 | Juvenile myoclonic epilepsy and Brugada type 1 ECG pattern associated with (a novel) plakophillin 2 mutation |
| Q72048760 | Juvenile myoclonic epilepsy and human leukocyte antigens |
| Q42629470 | Juvenile myoclonic epilepsy and idiopathic photosensitive occipital lobe epilepsy: is there overlap? |
| Q47945981 | Juvenile myoclonic epilepsy and narcolepsy: A series of three cases |
| Q47642397 | Juvenile myoclonic epilepsy and sleep |
| Q38113666 | Juvenile myoclonic epilepsy as a possible neurodevelopmental disease: role of EFHC1 or Myoclonin1. |
| Q39330327 | Juvenile myoclonic epilepsy as a spectrum disorder: A focused review |
| Q90346302 | Juvenile myoclonic epilepsy has hyper dynamic functional connectivity in the dorsolateral frontal cortex |
| Q67930159 | Juvenile myoclonic epilepsy in Sri Lanka |
| Q46474898 | Juvenile myoclonic epilepsy in a patient with history of infantile hemiplegia |
| Q48686724 | Juvenile myoclonic epilepsy in an elderly patient |
| Q80516354 | Juvenile myoclonic epilepsy in association with nonprogressive mental subnormality |
| Q34390863 | Juvenile myoclonic epilepsy in chromosome 6p12-p11: locus heterogeneity and recombinations |
| Q70413008 | Juvenile myoclonic epilepsy in unexpected age groups |
| Q44612191 | Juvenile myoclonic epilepsy is not associated with the DRPLA gene in a European population. |
| Q35644618 | Juvenile myoclonic epilepsy locus in chromosome 6p21.2-p11: linkage to convulsions and electroencephalography trait |
| Q46813872 | Juvenile myoclonic epilepsy masquerading as ecstasy withdrawal. |
| Q48468356 | Juvenile myoclonic epilepsy may be a disorder of cortex rather than thalamus: An effective connectivity analysis |
| Q93017924 | Juvenile myoclonic epilepsy mimic associated with CHD2 gene mutation |
| Q87433951 | Juvenile myoclonic epilepsy mimicking focal epilepsy |
| Q55062558 | Juvenile myoclonic epilepsy of Janz. |
| Q43451477 | Juvenile myoclonic epilepsy of Janz: clinical observations in 60 patients |
| Q92332534 | Juvenile myoclonic epilepsy phenotype in a family with Unverricht-Lundborg disease |
| Q35522785 | Juvenile myoclonic epilepsy presenting as a new daily persistent-like headache |
| Q88227140 | Juvenile myoclonic epilepsy refractory to treatment in a tertiary referral center |
| Q93230959 | Juvenile myoclonic epilepsy shows increased posterior theta, and reduced sensorimotor beta resting connectivity |
| Q46989550 | Juvenile myoclonic epilepsy starting in the eighth decade. |
| Q48625878 | Juvenile myoclonic epilepsy subsyndromes: family studies and long-term follow-up |
| Q46922657 | Juvenile myoclonic epilepsy with generalised and focal electroencephalographic abnormalities: a case report with a molecular genetic study |
| Q33878817 | Juvenile myoclonic epilepsy with multiple sclerosis: is there a dual role for valproate? |
| Q51618616 | Juvenile myoclonic epilepsy with photosensitivity in a female with Velocardiofacial syndrome (del(22)(q11.2))--causal relationship or coincidence? |
| Q43253346 | Juvenile myoclonic epilepsy with recurrent myoclonic status: efficacy of valproate |
| Q38531692 | Juvenile myoclonic epilepsy: A system disorder of the brain |
| Q46132587 | Juvenile myoclonic epilepsy: Authors' reply. |
| Q38963782 | Juvenile myoclonic epilepsy: Challenges on its 60th anniversary |
| Q39341487 | Juvenile myoclonic epilepsy: Clinical characteristics, standard and quantitative electroencephalography analyses |
| Q41811284 | Juvenile myoclonic epilepsy: EFHC1 at the cross-roads? |
| Q48161948 | Juvenile myoclonic epilepsy: a 5-year prospective study |
| Q51904231 | Juvenile myoclonic epilepsy: a benign disorder? Personality traits and psychiatric symptoms. |
| Q48686097 | Juvenile myoclonic epilepsy: a clinical and sleep EEG study |
| Q70389062 | Juvenile myoclonic epilepsy: a study in Saudi Arabia |
| Q73699492 | Juvenile myoclonic epilepsy: a study in Sri Lanka |
| Q69229386 | Juvenile myoclonic epilepsy: an autosomal recessive disease |
| Q30458723 | Juvenile myoclonic epilepsy: characteristics of a primary generalized epilepsy |
| Q74412457 | Juvenile myoclonic epilepsy: clinical and EEG features |
| Q74456107 | Juvenile myoclonic epilepsy: clinical characteristics, treatment and prognosis in a Norwegian population of patients |
| Q40591441 | Juvenile myoclonic epilepsy: diagnosis, management and outcome. |
| Q52900841 | Juvenile myoclonic epilepsy: disease expression among Indian families. |
| Q36622128 | Juvenile myoclonic epilepsy: epidemiology, pathophysiology, and management |
| Q48899693 | Juvenile myoclonic epilepsy: factors of error involved in the diagnosis and treatment |
| Q40658656 | Juvenile myoclonic epilepsy: is it an idiopathic epilepsy caused by a malformation of cortical development? |
| Q46172652 | Juvenile myoclonic epilepsy: linkage to chromosome 6p12 in Mexico families. |
| Q48950138 | Juvenile myoclonic epilepsy: long-term response to therapy |
| Q43146748 | Juvenile myoclonic epilepsy: more trials are needed to guide therapy |
| Q82611126 | Juvenile myoclonic epilepsy: non-classic electroencephalographical presentation in adult patients |
| Q38113671 | Juvenile myoclonic epilepsy: psychiatric comorbidity and impact on outcome |
| Q50735984 | Juvenile myoclonic epilepsy: the impact of clinical variables and psychiatric disorders on executive profile assessed with a comprehensive neuropsychological battery. |
| Q30495543 | Juvenile myoclonic epilepsy: the janz syndrome |
| Q35075606 | Juvenile myoclonic epilepsy: under-appreciated and under-diagnosed |
| Q36971923 | Juvenile myoclonic epilepsy: when will it end |
| Q57410964 | Lack of Association Between Juvenile Myoclonic Epilepsy and HLA-DR13 |
| Q73293987 | Lack of association between juvenile myoclonic epilepsy and GABRA5 and GABRB3 genes |
| Q85837121 | Lack of association between rs211037 of the GABRG2 gene and juvenile myoclonic epilepsy in Brazilian population |
| Q47997235 | Lack of heart rate variability during apnea in patients with juvenile myoclonic epilepsy (JME). |
| Q83333480 | Lacosamide treatment of juvenile myoclonic epilepsy |
| Q44980459 | Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: results of an open-label study |
| Q84205315 | Large motor unit territories by scanning electromyography in patients with juvenile myoclonic epilepsy |
| Q42381462 | Late-onset Juvenile Myoclonic Epilepsy or Frontal Lobe Epilepsy with Myoclonus |
| Q87955867 | Levetiracetam and Valproate Retention Rate in Juvenile Myoclonic Epilepsy |
| Q46824520 | Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents. |
| Q38026977 | Levetiracetam may worsen myoclonus in patients with juvenile myoclonic epilepsy: case reports |
| Q57053986 | Linkage analysis of idiopathic generalised epilepsy in families of probands with Juvenile Myoclonic Epilepsy and marker loci in the region of EPM 1 on chromosome 21 q: Unverricht-Lundborg disease and JME are not allelic variants |
| Q35195036 | Linkage analysis of idiopathic generalized epilepsy (IGE) and marker loci on chromosome 6p in families of patients with juvenile myoclonic epilepsy: no evidence for an epilepsy locus in the HLA region |
| Q35882342 | Linkage analysis of juvenile myoclonic epilepsy and microsatellite loci spanning 61 cM of human chromosome 6p in 19 nuclear pedigrees provides no evidence for a susceptibility locus in this region |
| Q43462933 | Localization of idiopathic generalized epilepsy on chromosome 6p in families of juvenile myoclonic epilepsy patients |
| Q92720910 | Long-term follow-up with therapeutic drug monitoring of antiepileptic drugs in patients with juvenile myoclonic epilepsy |
| Q71656667 | Long-term prognosis of typical childhood absence epilepsy: remission or progression to juvenile myoclonic epilepsy |
| Q73542108 | MR spectroscopy shows reduced frontal lobe concentrations of N-acetyl aspartate in patients with juvenile myoclonic epilepsy |
| Q92994403 | MRI endophenotypes of heritability and cognitive dysfunction in juvenile myoclonic epilepsy |
| Q95357654 | Major Susceptibility Genes for Common Idiopathic Epilepsies: ELP4 in Rolandic Epilepsy and BRD2 in Juvenile Myoclonic Epilepsy |
| Q69907189 | Mapping genes in juvenile myoclonic epilepsy |
| Q46469897 | Mental illness, personality traits and quality of life in epilepsy: control study of patients with juvenile myoclonic epilepsy and other epilepsies |
| Q91513325 | Meta-analysis of response inhibition in juvenile myoclonic epilepsy |
| Q91547467 | Methylation of cation-chloride cotransporters NKCC1 and KCC2 in patients with juvenile myoclonic epilepsy |
| Q63988296 | Microstructural and volumetric abnormalities of the putamen in juvenile myoclonic epilepsy |
| Q48251485 | Modulation of epileptiform EEG discharges in juvenile myoclonic epilepsy: an investigation of reflex epileptic traits |
| Q28262624 | Molecular analysis of the A322D mutation in the GABA receptor alpha-subunit causing juvenile myoclonic epilepsy |
| Q57766822 | Motor Co-Activation of Juvenile Myoclonic Epilepsy in Siblings |
| Q34044039 | Motor co-activation in siblings of patients with juvenile myoclonic epilepsy: an imaging endophenotype? |
| Q96692322 | Motor hyperactivation during cognitive tasks: An endophenotype of juvenile myoclonic epilepsy |
| Q35007877 | Motor system hyperconnectivity in juvenile myoclonic epilepsy: a cognitive functional magnetic resonance imaging study |
| Q84988877 | Motor unit territories in juvenile myoclonic epilepsy patients |
| Q28254851 | Mutation analyses of genes on 6p12-p11 in patients with juvenile myoclonic epilepsy |
| Q73473447 | Mutation analysis of the inwardly rectifying K(+) channels KCNJ6 (GIRK2) and KCNJ3 (GIRK1) in juvenile myoclonic epilepsy |
| Q28216597 | Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy |
| Q28272490 | Mutations in EFHC1 cause juvenile myoclonic epilepsy |
| Q28251815 | Mutations in the GABRA1 and EFHC1 genes are rare in familial juvenile myoclonic epilepsy |
| Q24297551 | Mutations of EFHC1, linked to juvenile myoclonic epilepsy, disrupt radial and tangential migrations during brain development |
| Q81343602 | Myoclonic seizures subside in the fourth decade in juvenile myoclonic epilepsy |
| Q95357675 | Myoclonin1/EFHC1 in cell division, neuroblast migration, synapse/dendrite formation in juvenile myoclonic epilepsy |
| Q35185047 | Neurodevelopment in new-onset juvenile myoclonic epilepsy over the first 2 years |
| Q99711198 | Neurophysiological and Genetic Findings in Patients With Juvenile Myoclonic Epilepsy |
| Q51182280 | Neurophysiology of juvenile myoclonic epilepsy: EEG-based network and graph analysis of the interictal and immediate preictal states. |
| Q46965896 | Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate |
| Q51907569 | Neuropsychological profile of patients with juvenile myoclonic epilepsy: a controlled study of 50 patients. |
| Q38409812 | Neuropsychological profiles of patients with juvenile myoclonic epilepsy and their siblings: An extended study |
| Q38384016 | Neuropsychological profiles of patients with juvenile myoclonic epilepsy and their siblings: a preliminary controlled experimental video-EEG case series |
| Q81801863 | No association of anti-GM1 and anti-GAD antibodies with juvenile myoclonic epilepsy: a pilot study |
| Q73473472 | No evidence for a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q |
| Q86889418 | No evidence of a role for cystatin B gene in juvenile myoclonic epilepsy |
| Q73835552 | No evidence of linkage to 6p markers in spanish families with juvenile myoclonic epilepsy |
| Q75331074 | Non-convulsive status epilepticus: a rare presentation of juvenile myoclonic epilepsy |
| Q74331527 | Nonconvulsion status epilepticus in patients with juvenile myoclonic epilepsy: types and frequencies |
| Q81343608 | Novel mutations in Myoclonin1/EFHC1 in sporadic and familial juvenile myoclonic epilepsy |
| Q51770701 | Observations on juvenile myoclonic epilepsy amongst ethnic Bengalees in West Bengal--an Eastern Indian State. |
| Q79824861 | Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy |
| Q37391845 | Ophthalmoplegic migraine with isolated third cranial nerve palsy in a known case of juvenile myoclonic epilepsy |
| Q87128578 | Optical coherence tomography parameters in patients with photosensitive juvenile myoclonic epilepsy |
| Q83133116 | Outcome of lamotrigine treatment in juvenile myoclonic epilepsy |
| Q93107009 | Outcomes of low-dose valproic acid treatment in patients with juvenile myoclonic epilepsy |
| Q58360420 | P-1033 - Serum S100B levels in first-episode psychosis and juvenile myoclonic epilepsy |
| Q49016896 | Patient page. Juvenile myoclonic epilepsy, a common epilepsy syndrome |
| Q81892393 | Personality profile of patients with juvenile myoclonic epilepsy |
| Q45335486 | Personality traits in juvenile myoclonic epilepsy: evidence of cortical abnormalities from a surface morphometry study |
| Q48694455 | Personality traits related to juvenile myoclonic epilepsy: MRI reveals prefrontal abnormalities through a voxel-based morphometry study |
| Q73235949 | Pharmacokinetics of valproic acid in patients with juvenile myoclonic epilepsy on monotherapy |
| Q40203760 | Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate |
| Q44416338 | Phenotypic analysis of juvenile myoclonic epilepsy in Indian families |
| Q54060526 | Possible association of juvenile myoclonic epilepsy with HLA-DRw6. |
| Q80472614 | Potential efficacy of zonisamide in refractory juvenile myoclonic epilepsy: retrospective evidence from an Irish compassionate-use case series |
| Q27311980 | Praxis-induced seizures in a patient with juvenile myoclonic epilepsy: MEG-EEG coregistration study. |
| Q88577132 | Predictive factors of higher drug load for seizure freedom in idiopathic generalized epilepsy: Comparison between juvenile myoclonic epilepsy and other types |
| Q38017730 | Predictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25-63 years of follow-up |
| Q96821449 | Predictors of Outcome in Juvenile Myoclonic Epilepsy |
| Q50636435 | Predictors of seizure control in patients with juvenile myoclonic epilepsy (JME). |
| Q47645824 | Prevalence and clinical characteristics of headache in juvenile myoclonic epilepsy: experience from a tertiary epilepsy center. |
| Q40468978 | Prevalence of juvenile myoclonic epilepsy in people <30 years of age-A population-based study in Norway. |
| Q91691416 | Prognosis of Juvenile myoclonic epilepsy with eye-closure sensitivity |
| Q44013868 | Prognosis of juvenile myoclonic epilepsy 45 years after onset: seizure outcome and predictors |
| Q60634583 | Prognosis of juvenile myoclonic epilepsy is related to endophenotypes |
| Q57036216 | Progressive dissociation of cortical and subcortical network development in children with new-onset juvenile myoclonic epilepsy |
| Q51031632 | Prospective memory in patients with juvenile myoclonic epilepsy and their healthy siblings. |
| Q31044694 | Proton magnetic resonance spectroscopy in juvenile myoclonic epilepsy: A systematic review and meta-analysis |
| Q40372400 | Psychiatric disorders among 165 patients with juvenile myoclonic epilepsy in India and association with clinical and sociodemographic variables |
| Q79905617 | Psychiatric disorders in juvenile myoclonic epilepsy: a controlled study of 100 patients |
| Q74137087 | Psychogenic seizures mimicking juvenile myoclonic epilepsy: case reports |
| Q90361787 | Psychosocial complications in juvenile myoclonic epilepsy |
| Q92317386 | Recovery function of somatosensory evoked potentials in juvenile myoclonic epilepsy |
| Q42631150 | Reduced axon number in juvenile myoclonic epilepsy demonstrated by motor unit number estimation analysis |
| Q84101089 | Reduced movement-related β desynchronisation in juvenile myoclonic epilepsy: a MEG study of task specific cortical modulation |
| Q91485963 | Refractory juvenile myoclonic epilepsy: a meta-analysis of prevalence and risk factors |
| Q80773401 | Regional grey matter abnormalities in juvenile myoclonic epilepsy: a voxel-based morphometry study |
| Q34145085 | Reproducibility and complications in gene searches: linkage on chromosome 6, heterogeneity, association, and maternal inheritance in juvenile myoclonic epilepsy |
| Q34402638 | Risk-taking behavior in juvenile myoclonic epilepsy |
| Q70398635 | Segregation analysis of juvenile myoclonic epilepsy |
| Q48870042 | Seizure threshold in juvenile myoclonic epilepsy with Graves disease |
| Q26798186 | Seizure-Control Effect of Levatiracetam on Juvenile Myoclonic Epilepsy and Other Epileptic Syndromes: Literature Review of Recent Studies |
| Q34294079 | Sex-specific behavioral traits in the Brd2 mouse model of juvenile myoclonic epilepsy |
| Q48256715 | Sleep disturbances in juvenile myoclonic epilepsy: a sleep questionnaire-based study |
| Q58381442 | Social rhythm and other chronobiological findings in juvenile myoclonic epilepsy |
| Q74149591 | Somatosensory evoked potentials and EEG findings in siblings of juvenile myoclonic epilepsy patients |
| Q47860731 | Source localization of epileptiform discharges in juvenile myoclonic epilepsy (JME) using magnetoencephalography (MEG). |
| Q40543656 | Status epilepticus in patients with juvenile myoclonic epilepsy: Frequency, precipitating factors and outcome |
| Q91543670 | Structural and functional connectivity in newly diagnosed juvenile myoclonic epilepsy |
| Q37155051 | Structural brain abnormalities in juvenile myoclonic epilepsy patients: volumetry and voxel-based morphometry |
| Q72361142 | Subclinical anterior horn cell involvement in juvenile myoclonic epilepsy |
| Q92629016 | Subcortical gray matter changes in pediatric patients with new-onset juvenile myoclonic epilepsy |
| Q44258332 | Subcortical structural abnormalities in juvenile myoclonic epilepsy (JME): MR volumetry and vertex based analysis |
| Q90704624 | Subtle Brain Developmental Abnormalities in the Pathogenesis of Juvenile Myoclonic Epilepsy |
| Q104682081 | Surround inhibition in patients with juvenile myoclonic epilepsy |
| Q40483974 | Susceptibility Gene for Juvenile Myoclonic Epilepsy Rings True. |
| Q51056060 | Terminal remission is possible in some patients with juvenile myoclonic epilepsy without therapy. |
| Q96124123 | Thalamic and cortical hyperexcitability in juvenile myoclonic epilepsy |
| Q44667917 | Thalamic dysfunction in juvenile myoclonic epilepsy: a proton MRS study |
| Q91348888 | Thalamic nuclei volumes and network in juvenile myoclonic epilepsy |
| Q96226639 | The Association Between Temperament Features And Childhood Traumas In Patients With Juvenile Myoclonic Epilepsy |
| Q92252741 | The Timing, Nature, and Range of Neurobehavioral Comorbidities in Juvenile Myoclonic Epilepsy |
| Q27308026 | The developmental evolution of the seizure phenotype and cortical inhibition in mouse models of juvenile myoclonic epilepsy |
| Q48492831 | The effect of electrophysiological and neuroimaging findings on the prognosis of juvenile myoclonic epilepsy proband |
| Q33496263 | The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent? |
| Q88736382 | The genetic basis of juvenile myoclonic epilepsy |
| Q72227451 | The genetics of idiopathic generalized epilepsies of adolescent onset: differences between juvenile myoclonic epilepsy and epilepsy with random grand mal and with awakening grand mal |
| Q28267274 | The juvenile myoclonic epilepsy GABA(A) receptor alpha1 subunit mutation A322D produces asymmetrical, subunit position-dependent reduction of heterozygous receptor currents and alpha1 subunit protein expression |
| Q34373916 | The juvenile myoclonic epilepsy mutant of the calcium channel β(4) subunit displays normal nuclear targeting in nerve and muscle cells |
| Q28586806 | The mouse ortholog of EFHC1 implicated in juvenile myoclonic epilepsy is an axonemal protein widely conserved among organisms with motile cilia and flagella |
| Q38113665 | The quest for juvenile myoclonic epilepsy genes |
| Q95943652 | The role of cortisol in trust behavior: Results from an experimental study on healthy controls and patients with juvenile myoclonic epilepsy |
| Q67930131 | The seizure prognosis of juvenile myoclonic epilepsy |
| Q48294728 | The sleep-deprived brain in normals and patients with juvenile myoclonic epilepsy: a perturbational approach to measuring cortical reactivity |
| Q48408517 | The topographical distribution of epileptic spikes in juvenile myoclonic epilepsy with and without photosensitivity |
| Q71507539 | The use of lamotrigine in juvenile myoclonic epilepsy |
| Q91245218 | Topiramate for juvenile myoclonic epilepsy |
| Q24186962 | Topiramate monotherapy for juvenile myoclonic epilepsy |
| Q24201882 | Topiramate monotherapy for juvenile myoclonic epilepsy |
| Q53483475 | Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison. |
| Q103829184 | Trait impulsivity in Juvenile Myoclonic Epilepsy |
| Q27002409 | Transition issues for benign epilepsy with centrotemporal spikes, nonlesional focal epilepsy in otherwise normal children, childhood absence epilepsy, and juvenile myoclonic epilepsy |
| Q92078542 | Treatment and challenges with antiepileptic drugs in patients with juvenile myoclonic epilepsy |
| Q91477086 | Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential |
| Q37129788 | Treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy |
| Q41255182 | Treatment of pyknoleptic petit mal epilepsy and juvenile myoclonic epilepsy with dipropyl acetate (Deprakine). A pilot study of therapy-resistant patients during control of plasma concentration |
| Q37634650 | Two patients diagnosed with juvenile myoclonic epilepsy by first-ever status epilepticus in adult life |
| Q64970250 | Two patients with juvenile myoclonic epilepsy and nonconvulsive status epilepticus. |
| Q33868577 | Understanding juvenile myoclonic epilepsy: contributions from neuroimaging. |
| Q74477326 | Valproate as monotherapy for juvenile myoclonic epilepsy: dose-effect study |
| Q74209609 | Valproate lowered the amplitude of visual and somatosensory evoked potentials in two cases of untreated juvenile myoclonic epilepsy |
| Q48771066 | Valproate monotherapy in juvenile myoclonic epilepsy: dose-related effects on electroencephalographic and other neurophysiologic tests |
| Q95366931 | Valproic acid-induced pancreatitis in a 15-year-old boy with juvenile myoclonic epilepsy |
| Q34739231 | West syndrome followed by juvenile myoclonic epilepsy: a coincidental occurrence? |
| Q91264671 | Whole exome sequencing identifies a novel SCN1A mutation in genetic (idiopathic) generalized epilepsy and juvenile myoclonic epilepsy subtypes |
| Q48644313 | Widespread cortical morphologic changes in juvenile myoclonic epilepsy: evidence from structural MRI. |
| Q71389679 | [A clinico-genealogical study of a family with juvenile myoclonic epilepsy] |
| Q77704493 | [Analysis of the changes observed in the sleep EEG recording of patients with juvenile myoclonic epilepsy] |
| Q91423387 | [Clinical and psychosocial factors associated with seizure control in patients with juvenile myoclonic epilepsy] |
| Q82986136 | [Clinical factors related to treatment resistance in juvenile myoclonic epilepsy] |
| Q70957755 | [Clinical-electrophysiological pattern of juvenile myoclonic epilepsy] |
| Q78137429 | [Clinical-epidemiological study of patients with juvenile myoclonic epilepsy in Santa Catarina State, Brazil] |
| Q78174519 | [Electroencephalographic studies of family members of patients with juvenile myoclonic epilepsy] |
| Q77165868 | [Genetic aspects of juvenile myoclonic epilepsy] |
| Q64925182 | [Janz's juvenile myoclonic epilepsy: a little-known frequent syndrome. A study of 85 patients] |
| Q74462607 | [Juvenile myoclonic epilepsy (Janz syndrome). A well-known epilepsy syndrome?] |
| Q78398779 | [Juvenile myoclonic epilepsy in chromosome 6p12: clinical and genetic advances] |
| Q73050396 | [Juvenile myoclonic epilepsy misdiagnosed as focal epilepsy: variability of myoclonic seizures] |
| Q53726252 | [Juvenile myoclonic epilepsy with cherry-red spot in the fundus oculi. II. Histological and ultrastructural study of the hepatic biopsy] |
| Q69282587 | [Juvenile myoclonic epilepsy: Janz' syndrome] |
| Q67262162 | [Juvenile myoclonic epilepsy: a prospective study of 13 cases] |
| Q90092183 | [Juvenile myoclonic epilepsy: long-term prognosis and antiepileptic drug withdrawal] |
| Q85038917 | [Juvenile myoclonic epilepsy: under-diagnosed syndrome] |
| Q71201111 | [Misleading aspects of the standard electroencephalogram in juvenile myoclonic epilepsy: a retrospective study of 56 consecutive cases] |
| Q80046204 | [Myoclonic seizures induced by tramadol in patients with juvenile myoclonic epilepsy] |
| Q52136304 | [Psychiatric disorders in juvenile myoclonic epilepsy] |
| Q81361305 | [Study on interictal epileptiform discharges in juvenile myoclonic epilepsy patient with EEG-fMRI] |
| Q73075116 | [Treatment of juvenile myoclonic epilepsy with low-dose sodium valproate] |